Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
Arzerra receives approval in Japan
Daclizumab (Zinbryta) for multiple sclerosis.
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis.
Neuromyelitis optica accompanied by nephrotic syndrome and autoimmune-related pancytopenia.
Anterograde-propagation of axonal degeneration in the visual system of wlds mice characterized by diffusion tensor imaging.
Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Metabolic determinants of the immune modulatory function of neural stem cells.
Leukodystrophies.
Reduced fecal GABA levels in multiple sclerosis patients.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
S100A8/A9: From basic science to clinical application.
Evidence in sexual assault case ruled out.
Epigenetic Aspects of Systemic Lupus Erythematosus.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system.
Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Gamified Design for Health Workshop.
A mouse model for testing remyelinating therapies.
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency.
The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.

Pages